Wellington Management Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.8M Sell
90,736
-9,410
-9% -$1.83M ﹤0.01% 1064
2025
Q4
$17.4M Sell
100,146
-1,341,737
-93% -$244M ﹤0.01% 1086
2025
Q3
$275M Sell
1,441,883
-157,333
-10% -$27.9M 0.05% 317
2025
Q2
$287M Sell
1,599,216
-159,049
-9% -$27.6M 0.05% 275
2025
Q1
$297M Sell
1,758,265
-25,903
-1% -$4.26M 0.06% 262
2024
Q4
$269M Sell
1,784,168
-549,280
-24% -$85.4M 0.05% 297
2024
Q3
$362M Sell
2,333,448
-217,344
-9% -$32.5M 0.06% 260
2024
Q2
$349M Sell
2,550,792
-61,977
-2% -$8.49M 0.06% 262
2024
Q1
$348M Sell
2,612,769
-19,557
-0.7% -$2.54M 0.06% 289
2023
Q4
$363M Buy
2,632,326
+18,533
+0.7% +$2.44M 0.07% 274
2023
Q3
$319M Buy
2,613,793
+333,947
+15% +$44.5M 0.06% 277
2023
Q2
$320M Buy
2,279,846
+365,292
+19% +$50.4M 0.06% 287
2023
Q1
$271M Buy
1,914,554
+1,910,403
+46,023% +$273M 0.05% 323
2022
Q4
$649K Sell
4,151
-1,904
-31% -$274K ﹤0.01% 1760
2022
Q3
$743K Buy
6,055
+659
+12% +$86.8K ﹤0.01% 1707
2022
Q2
$717K Sell
5,396
-1,058
-16% -$144K ﹤0.01% 1731
2022
Q1
$883K Sell
6,454
-63,218
-91% -$8.81M ﹤0.01% 1760
2021
Q4
$12.1M Sell
69,672
-9,994
-13% -$1.52M ﹤0.01% 1208
2021
Q3
$11.6M Buy
79,666
+399
+0.5% +$58.4K ﹤0.01% 1233
2021
Q2
$10.5M Sell
79,267
-737,820
-90% -$96.6M ﹤0.01% 1258
2021
Q1
$105M Sell
817,087
-20,396
-2% -$2.51M 0.02% 603
2020
Q4
$99.8M Buy
837,483
+5,841
+0.7% +$712K 0.02% 591
2020
Q3
$95.2M Buy
831,642
+741,537
+823% +$87.6M 0.02% 529
2020
Q2
$10.3M Buy
90,105
+78,919
+706% +$8.37M ﹤0.01% 1060
2020
Q1
$898K Sell
11,186
-35,369
-76% -$3.66M ﹤0.01% 1561
2019
Q4
$4.97M Sell
46,555
-4,124
-8% -$430K ﹤0.01% 1338
2019
Q3
$5.42M Buy
50,679
+13,261
+35% +$1.36M ﹤0.01% 1328
2019
Q2
$3.81M Sell
37,418
-2,637
-7% -$253K ﹤0.01% 1441
2019
Q1
$3.6M Sell
40,055
-3,743
-9% -$324K ﹤0.01% 1461
2018
Q4
$3.65M Buy
43,798
+5,669
+15% +$531K ﹤0.01% 1467
2018
Q3
$4.11M Sell
38,129
-3,317
-8% -$364K ﹤0.01% 1529
2018
Q2
$4.56M Sell
41,446
-89,335
-68% -$9.31M ﹤0.01% 1518
2018
Q1
$13.1M Sell
130,781
-110,445
-46% -$11.3M ﹤0.01% 1205
2017
Q4
$23.8M Sell
241,226
-194,419
-45% -$18.4M 0.01% 1016
2017
Q3
$40.8M Sell
435,645
-20,060
-4% -$2.13M 0.01% 813
2017
Q2
$50.7M Buy
455,705
+86,346
+23% +$9.13M 0.01% 728
2017
Q1
$36.3M Buy
369,359
+160,723
+77% +$15.3M 0.01% 833
2016
Q4
$19.2M Buy
208,636
+96,214
+86% +$8.29M ﹤0.01% 1019
2016
Q3
$9.52M Sell
112,422
-5,704
-5% -$479K ﹤0.01% 1194
2016
Q2
$9.62M Buy
118,126
+59,568
+102% +$4.54M ﹤0.01% 1154
2016
Q1
$4.18M Sell
58,558
-8,376
-13% -$562K ﹤0.01% 1407
2015
Q4
$4.76M Buy
66,934
+3,057
+5% +$206K ﹤0.01% 1371
2015
Q3
$3.93M Buy
63,877
+750
+1% +$52.4K ﹤0.01% 1426
2015
Q2
$4.58M Sell
63,127
-5,907
-9% -$436K ﹤0.01% 1428
2015
Q1
$5.3M Buy
69,034
+4,793
+7% +$343K ﹤0.01% 1434
2014
Q4
$4.31M Buy
64,241
+60,427
+1,584% +$3.81M ﹤0.01% 1482
2014
Q3
$232K Sell
3,814
-1,373
-26% -$84.6K ﹤0.01% 2114
2014
Q2
$304K Buy
5,187
+1,437
+38% +$84.2K ﹤0.01% 2071
2014
Q1
$217K Buy
+3,750
New +$201K ﹤0.01% 2105

Other funds holding DGX

Wellington Management Group's DGX Position: Q1 2026 in Review

Wellington Management Group reduced its Quest Diagnostics (DGX) stake by 9.4% in Q1 2026, selling an estimated $1.83M and leaving 90,736 shares worth $17.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1064.

Wellington Management Group first reported a position in DGX in Q1 2014 and has held it in 49 quarters since. The position peaked at $363M in Q4 2023. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Wellington Management Group held 90,736 shares of Quest Diagnostics worth $17.8M as of Q1 2026.
  • Wellington Management Group sold 9,410 Quest Diagnostics shares in Q1 2026, an estimated $1.83M.
  • Quest Diagnostics made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1064 holding.
  • Wellington Management Group first reported a position in Quest Diagnostics in Q1 2014 and has held it in 49 quarters since.
  • Wellington Management Group's Quest Diagnostics position peaked at $363M in Q4 2023.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.